ATE400300T1 - Polyamin-metallchelatbildner-konjugate - Google Patents

Polyamin-metallchelatbildner-konjugate

Info

Publication number
ATE400300T1
ATE400300T1 AT04783536T AT04783536T ATE400300T1 AT E400300 T1 ATE400300 T1 AT E400300T1 AT 04783536 T AT04783536 T AT 04783536T AT 04783536 T AT04783536 T AT 04783536T AT E400300 T1 ATE400300 T1 AT E400300T1
Authority
AT
Austria
Prior art keywords
polyamine
moiety
metal chelating
conjugates
chelator
Prior art date
Application number
AT04783536T
Other languages
German (de)
English (en)
Inventor
Raymond Bergeron
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of ATE400300T1 publication Critical patent/ATE400300T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyethers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT04783536T 2003-09-09 2004-09-09 Polyamin-metallchelatbildner-konjugate ATE400300T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50134103P 2003-09-09 2003-09-09

Publications (1)

Publication Number Publication Date
ATE400300T1 true ATE400300T1 (de) 2008-07-15

Family

ID=34273034

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04783536T ATE400300T1 (de) 2003-09-09 2004-09-09 Polyamin-metallchelatbildner-konjugate

Country Status (8)

Country Link
US (1) US20080096974A2 (cg-RX-API-DMAC7.html)
EP (1) EP1667727B1 (cg-RX-API-DMAC7.html)
JP (1) JP2007505044A (cg-RX-API-DMAC7.html)
AT (1) ATE400300T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004270261B2 (cg-RX-API-DMAC7.html)
CA (1) CA2538159A1 (cg-RX-API-DMAC7.html)
DE (1) DE602004014949D1 (cg-RX-API-DMAC7.html)
WO (1) WO2005023310A2 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083966A (en) 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
WO2005034949A1 (en) 2003-09-09 2005-04-21 University Of Florida Desferrithiocin derivatives and their use as iron chelators
US20070149496A1 (en) * 2003-10-31 2007-06-28 Jack Tuszynski Water-soluble compound
EP1866296B1 (en) 2005-04-04 2016-11-02 University of Florida Research Foundation, Inc. Desferrithiocin polyether analogues
CA2645666A1 (en) * 2006-03-15 2007-09-20 Mallinckrodt Inc. Chelating conjugates having a substituted aromatic moiety and derivatives thereof
AU2007351826A1 (en) * 2006-12-12 2008-10-30 University Of Florida Research Foundation, Inc. Desferrithiocin analogue actinide decorporation agents
NZ579994A (en) * 2007-03-15 2011-09-30 Univ Florida Desferrithiocin polyether analogues useful in the treatment of pathological conditions responsive to chelation or sequestration of trivalent metal
WO2009055863A1 (en) * 2007-11-01 2009-05-07 The University Of Sydney Desferrioxamine conjugates, derivatives and analogues
CN102317440B (zh) * 2008-01-09 2014-12-03 塞尔卡有限公司 改进的培养基添加剂及其应用方法
US9259670B2 (en) 2008-04-16 2016-02-16 The University Of Kentucky Research Foundation Flow-through filter to remove aluminum from medical solutions
US7932326B2 (en) * 2008-04-16 2011-04-26 The University Of Kentucky Research Foundation Chelating compounds and immobilized tethered chelators
CN103435569B (zh) 2008-07-14 2015-08-19 法罗肯生物科学公司 作为金属螯合剂的脱氮杂去铁硫辛聚醚类似物的新型盐和多晶型物
WO2011109521A1 (en) 2010-03-02 2011-09-09 University Of Kansas Polyamine-dihydroxybenzoic acid conjugate hydrogels as iron chelators
JP2013525495A (ja) * 2010-05-04 2013-06-20 シャイアー・リミテッド・ライアビリティ・カンパニー 金属キレート化剤としてのデスアザデスフェリチオシン類似体
KR102111176B1 (ko) 2011-12-16 2020-05-15 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 4'-데스페리티오신 유사체의 용도
FR2984317B1 (fr) 2011-12-20 2015-02-27 Univ Rennes Composes chelateurs de metal presentant au moins une chaine polyaminee.
AU2014352780A1 (en) 2013-11-22 2016-06-09 University Of Florida Research Foundation, Inc. Desferrithiocin analogs and uses thereof
WO2016176343A1 (en) 2015-04-27 2016-11-03 University Of Florida Research Foundation, Incorporated Metabolically programmed metal chelators and uses thereof
KR102723249B1 (ko) 2016-04-29 2024-10-28 오피렉스, 인크. 벌목 유독동물독소중독으로 인한 용혈, 뇌부종, 및 급성 신손상의 치료를 위한 pla2 및 hmg-coa 억제제
WO2020092464A1 (en) 2018-10-30 2020-05-07 The Research Foundation For The State University Of New York Compositions and methods for removal of negatively charged impurities using metal-cellulose fiber composite

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342945A (en) * 1986-12-02 1994-08-30 University Of Florida Research Foundation, Inc. Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
US6184232B1 (en) * 1986-12-02 2001-02-06 University Of Florida Analogs of biologically active, naturally occurring polyamines, pharmaceutical compositions and methods of treatment
US5091576A (en) * 1986-12-02 1992-02-25 University Of Florida Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
US5554748A (en) * 1989-04-07 1996-09-10 Nycomed Salutar, Inc. Adducts of macrocyclic chelants
JPH06505996A (ja) * 1991-08-23 1994-07-07 フアイザー・インコーポレイテツド 興奮性アミノ酸系神経伝達物質アンタゴニストとしての合成アリールポリアミン
US5493053A (en) * 1994-12-21 1996-02-20 University Of Florida Research Foundation, Inc. Method for preparing desferrioxamine B and homologs thereof
US5886051A (en) * 1995-11-08 1999-03-23 University Of Florida Research Foundation, Inc. Methods and compositions for the treatment of neurodegeneration
US5739395A (en) * 1997-01-10 1998-04-14 University Of Florida Research Foundation, Inc. Method for synthesis of rhizoferrin
US6653299B1 (en) * 1997-01-21 2003-11-25 Nycomed Amersham Plc Labelled factor XIIIa substrates
US6083966A (en) * 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
WO2004017959A2 (en) * 2002-08-22 2004-03-04 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
US20040044220A1 (en) * 2002-08-22 2004-03-04 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin

Also Published As

Publication number Publication date
AU2004270261B2 (en) 2008-12-04
AU2004270261A1 (en) 2005-03-17
EP1667727A2 (en) 2006-06-14
CA2538159A1 (en) 2005-03-17
JP2007505044A (ja) 2007-03-08
EP1667727B1 (en) 2008-07-09
US20080096974A2 (en) 2008-04-24
DE602004014949D1 (de) 2008-08-21
US20060211773A1 (en) 2006-09-21
WO2005023310A3 (en) 2005-04-21
WO2005023310A2 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
ATE400300T1 (de) Polyamin-metallchelatbildner-konjugate
BR0112969A (pt) Método de utilização de dicetopiperazinas e composições contendo-as
ATE469211T1 (de) Verbesserte sso7-polymerase-konjugat-proteine
BRPI0608886B8 (pt) derivados de n-sulfonilpirróis e seus usos
DE60004172D1 (de) Gcsf konjugate
CA2462085A1 (en) Cytotoxic agents
BR9608012A (pt) Agentes de amidino cíclicos úteis como inbidores da sintase do óxido nítrico
BR0112701B1 (pt) retentor de aba cranial.
BR9916798A (pt) 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek
DK1129093T3 (da) Pyrazolopyrimidinonderivater til behandling af impotens
DE60234028D1 (de) Hydantion-derivate als hemmer von matrix-metalloproteinasen
UA95959C2 (en) Leptomycin derivatives
WO2006124737A3 (en) Molecular constructs suitable for targeted conjugates
WO2005067644A3 (en) Conjugated small molecules
DK1237584T3 (da) Receptorbindende konjugater
ATE405435T1 (de) Wunschkarte
IN2012DN02609A (cg-RX-API-DMAC7.html)
TW200719539A (en) Fluorescent tube attaching structure
DE60230137D1 (de) Zusammensetzungen enthaltend lipid-polymer konjugate
DE50109451D1 (de) Blechklammer
TR200402787T4 (tr) @İkameliÁ}SBÁNikotinÁtürevleriÁveÁaraÁbileşikleriÁüretmeÁmetodu
AU6683900A (en) Conjugate for mediating cell, compartment or membrane-specific transport of active substances
DE60126503D1 (de) Strumpfmanschette für stenteinführungskatheter
DK1351709T3 (da) Pegylering af linkere forbedrer antitumorvirkning og reducerer immunkonjugaters tokcitet
ITBO20000356A0 (it) Metodo e dispositivo di prelievo di pile di sbozzati .

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties